Ferrer, Leti and Oryzon to collaborate in R&D
Catalan Economy
21 Nov 2009
Pharmaceutical companies Ferrer and Leti and biotech firm Oryzon have announced the creation of the Oncochip alliance to further develop cancer research in Catalonia. Madrid-based Ingenasa and Navarra’s CIMA are also to participate in the project.
With a budget of over EUR 20 million, Oncochip will focus on the design of therapies for early diagnosis of ovarian cancer, melanoma and colon cancer. Oryzon specializes in the detection of cancer biomarkers and is already working with Reig Jofré on uterine cancer research.
Ferrer, Leti and Oryzon also plan to create a new partnership next year to develop nanotechnology projects.
Source: Expansión Cataluña 16/11/2009
Related News and Success stories.
-
02 Mar 2026
See more Catalonia ranks 8th globally for attracting tech and digital foreign investment projectsCatalonia ranks 8th globally for attracting tech and digital foreign investment projects
-
26 Feb 2026
See more Catalonia’s packaging industry reaches €12.2 billion with 855 companies and a strong global presenceCatalonia’s packaging industry reaches €12.2 billion with 855 companies and a strong global presence
-
24 Feb 2026
See more Catalan Exhibitors at Mobile World Congress 2026Catalan Exhibitors at Mobile World Congress 2026
-
23 Feb 2026
See more The number of startups in Catalonia hits 2,403 in 2025, 5.2% over the previous year, and the highest figure on recordThe number of startups in Catalonia hits 2,403 in 2025, 5.2% over the previous year, and the highest figure on record
